Hepion Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGHepion Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings growth of 97% provides fundamental context to the price action. Investors should exercise caution due to high volatility (246% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.06 | +0.84% | ABOVE |
| 50 SMA | $0.06 | -5.51% | BELOW |
| 100 SMA | $0.05 | +9.29% | ABOVE |
| 150 SMA | $0.06 | +3.99% | ABOVE |
| 200 SMA | $0.06 | -0.17% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is HEPA in an uptrend right now?
HEPA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is HEPA overbought or oversold?
HEPA's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is HEPA outperforming the market?
HEPA has a Relative Strength (RS) Rating of 90 out of 99. Yes, HEPA is a market leader, outperforming 90% of all stocks over the past 12 months.
Where is HEPA in its 52-week range?
HEPA is trading at $0.06, which is 24% of its 52-week high ($0.25) and 12% above its 52-week low ($0.03).
How volatile is HEPA?
HEPA has a Beta of 0.56 and 52-week volatility of 246%. It's less volatile than the S&P 500 - generally more stable.